Needle-free Injectors Market (By Product: Fillable, Prefilled; By Technology; By Type; By Application; By Usability; By Delivery Site; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global needle-free Injectors market was valued at USD 124.2 million in 2021 and it is predicted to surpass around USD 276.3 million by 2030 with a CAGR of 9.29% from 2022 to 2030.

Needle-free Injectors Market Size 2021 to 2030

An increasing number of infectious diseases across the globe is escalating the demand for self-injection devices, and the rising need for vaccination is the major factor projected to fuel the market growth. An increase in the geriatric population base developing communicable diseases due to needle stick injuries is estimated to surge the demand for needle-free Injectors over the forecast period. Additionally, the rising focus of market players on developing safe, pain-free, and advanced injectors is expected to augment the market expansion.

Recent advancements and product approvals as well as upgradation in needle-free injectors are anticipated to contribute towards market growth. In August 2022, WHO nominated the PharmaJet Tropis needle-free Injection System for huge polio vaccination campaigns. In July 2022, NuGen Medical Devices Inc. announced that its InsuJet has been approved and accepted by Health Canada explicitly for the needle-free delivery of insulin.

Injections are one of the most common medical devices used for drug administration. Due to this, healthcare professionals are at great risk of exposure to bloodborne pathogens owing to needle stick injuries, which can occur accidentally. According to Occupational Safety and Health Administration (OSHA), around 590,000 needle stick accidents occur each year.

Asia Pacific region is estimated to exhibit the highest CAGR during the forecast period owing to increasing investments in the region by key market players, and rapid development of the healthcare industry in countries such as India, China, Japan, and others. Availability of low-cost labor for manufacturing, growing demand for self-injection devices, and the presence of favorable regulatory scenarios are major factors anticipated to create wide growth opportunities for current and upcoming market players.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 124.2 million
Revenue Forecast by 2030 USD 276.3 million 
Growth rate from 2022 to 2030 CAGR of 9.29%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Product, Technology, Type, Application, Usability, Delivery Site, End-use, Region
Companies Covered

PharmaJet, Crossject, Portal Instruments, NuGen Medical Devices, Inovio Pharmaceuticals, Antares Pharma, Inc, Aijex Pharma International Inc., Ferring B.V., Penjet Corporation, and Medical International Technology Inc.

 

Key Players

  • PharmaJet
  • Crossject
  • Portal Instruments
  • NuGen Medical Devices
  • Inovio Pharmaceuticals
  • Antares Pharma, Inc
  • Aijex Pharma International Inc.
  • Ferring B.V.
  • Penjet Corporation
  • Medical International Technology Inc.

Market Segmentation

  • By Product
    •  Fillable
    • Prefilled
  • By Technology
    • Spring-based needle-free Injectors
    • Gas-powered needle-free Injectors
    • Laser-powered needle-free Injectors
    • Vibration-based needle-free Injectors
  • By Type
    • Powder-based needle-free Injectors
    • Liquid-based needle-free Injectors
    • Projectile/depot-based needle-free Injectors
  • By Application
    • Vaccine Delivery
    • Insulin Delivery
    • Pain Management
    • Others
  • By Usability
    • Reusable
    • Disposable
  • By Delivery Site
    • Subcutaneous
    • Intramuscular
    • Intradermal
  • By End-use
    • Hospitals & Clinics
    • Home Care Settings
    • Research Laboratories
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Needle-free Injectors Market, By Product

7.1. Needle-free Injectors Market, by Product, 2022-2030

7.1.1. Fillable

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Prefilled

7.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Needle-free Injectors Market, By Technology

8.1. Needle-free Injectors Market, by Technology, 2022-2030

8.1.1. Spring-based needle-free Injectors

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Gas-powered needle-free Injectors

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Laser-powered needle-free Injectors

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Vibration-based needle-free Injectors

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Needle-free Injectors Market, By Type

9.1. Needle-free Injectors Market, by Type, 2022-2030

9.1.1. Powder-based needle-free Injectors

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Liquid-based needle-free Injectors

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Projectile/depot-based needle-free Injectors

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Needle-free Injectors Market, By Application

10.1. Needle-free Injectors Market, by Application, 2022-2030

10.1.1. Vaccine Delivery

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Insulin Delivery

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Pain Management

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Needle-free Injectors Market, By Usability

11.1. Needle-free Injectors Market, by Usability, 2022-2030

11.1.1. Reusable

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Disposable

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Needle-free Injectors Market, By Delivery Site

12.1. Needle-free Injectors Market, by Delivery Site, 2022-2030

12.1.1. Subcutaneous

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Intramuscular

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Intradermal

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Needle-free Injectors Market, By End-use

13.1. Needle-free Injectors Market, by End-use, 2022-2030

13.1.1. Hospitals & Clinics

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Home Care Settings

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Research Laboratories

13.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Needle-free Injectors Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.2. Market Revenue and Forecast, by Technology (2017-2030)

14.1.3. Market Revenue and Forecast, by Type (2017-2030)

14.1.4. Market Revenue and Forecast, by Application (2017-2030)

14.1.5. Market Revenue and Forecast, by Usability (2017-2030)

14.1.6. Market Revenue and Forecast, by End-use (2017-2030)

14.1.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.8.2. Market Revenue and Forecast, by Technology (2017-2030)

14.1.8.3. Market Revenue and Forecast, by Type (2017-2030)

14.1.8.4. Market Revenue and Forecast, by Application (2017-2030)

14.1.8.5. Market Revenue and Forecast, by Usability (2017-2030)

14.1.8.6. Market Revenue and Forecast, by End-use (2017-2030)

14.1.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Technology (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Type (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Application (2017-2030)

14.1.9.5. Market Revenue and Forecast, by Usability (2017-2030)

14.1.9.6. Market Revenue and Forecast, by End-use (2017-2030)

14.1.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.2. Market Revenue and Forecast, by Technology (2017-2030)

14.2.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.4. Market Revenue and Forecast, by Application (2017-2030)

14.2.5. Market Revenue and Forecast, by Usability (2017-2030)

14.2.6. Market Revenue and Forecast, by End-use (2017-2030)

14.2.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.8.4. Market Revenue and Forecast, by Application (2017-2030)

14.2.8.5. Market Revenue and Forecast, by Usability (2017-2030)

14.2.8.6. Market Revenue and Forecast, by End-use (2017-2030)

14.2.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.9.2. Market Revenue and Forecast, by Technology (2017-2030)

14.2.9.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.9.4. Market Revenue and Forecast, by Application (2017-2030)

14.2.9.5. Market Revenue and Forecast, by Usability (2017-2030)

14.2.9.6. Market Revenue and Forecast, by End-use (2017-2030)

14.2.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.10.2. Market Revenue and Forecast, by Technology (2017-2030)

14.2.10.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.10.4. Market Revenue and Forecast, by Application (2017-2030)

14.2.10.5. Market Revenue and Forecast, by Usability (2017-2030)

14.2.10.6. Market Revenue and Forecast, by End-use (2017-2030)

14.2.10.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Technology (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Type (2017-2030)

14.2.11.4. Market Revenue and Forecast, by Application (2017-2030)

14.2.11.5. Market Revenue and Forecast, by Usability (2017-2030)

14.2.11.6. Market Revenue and Forecast, by End-use (2017-2030)

14.2.11.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.2. Market Revenue and Forecast, by Technology (2017-2030)

14.3.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.5. Market Revenue and Forecast, by Usability (2017-2030)

14.3.6. Market Revenue and Forecast, by End-use (2017-2030)

14.3.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

14.3.8.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.8.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.8.5. Market Revenue and Forecast, by Usability (2017-2030)

14.3.8.6. Market Revenue and Forecast, by End-use (2017-2030)

14.3.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.9.2. Market Revenue and Forecast, by Technology (2017-2030)

14.3.9.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.9.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.9.5. Market Revenue and Forecast, by Usability (2017-2030)

14.3.9.6. Market Revenue and Forecast, by End-use (2017-2030)

14.3.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Technology (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.10.5. Market Revenue and Forecast, by Usability (2017-2030)

14.3.10.6. Market Revenue and Forecast, by End-use (2017-2030)

14.3.10.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.11.2. Market Revenue and Forecast, by Technology (2017-2030)

14.3.11.3. Market Revenue and Forecast, by Type (2017-2030)

14.3.11.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.11.5. Market Revenue and Forecast, by Usability (2017-2030)

14.3.11.6. Market Revenue and Forecast, by End-use (2017-2030)

14.3.11.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.2. Market Revenue and Forecast, by Technology (2017-2030)

14.4.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.5. Market Revenue and Forecast, by Usability (2017-2030)

14.4.6. Market Revenue and Forecast, by End-use (2017-2030)

14.4.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

14.4.8.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.8.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.8.5. Market Revenue and Forecast, by Usability (2017-2030)

14.4.8.6. Market Revenue and Forecast, by End-use (2017-2030)

14.4.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.9.2. Market Revenue and Forecast, by Technology (2017-2030)

14.4.9.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.9.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.9.5. Market Revenue and Forecast, by Usability (2017-2030)

14.4.9.6. Market Revenue and Forecast, by End-use (2017-2030)

14.4.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Technology (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.10.5. Market Revenue and Forecast, by Usability (2017-2030)

14.4.10.6. Market Revenue and Forecast, by End-use (2017-2030)

14.4.10.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.11.2. Market Revenue and Forecast, by Technology (2017-2030)

14.4.11.3. Market Revenue and Forecast, by Type (2017-2030)

14.4.11.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.11.5. Market Revenue and Forecast, by Usability (2017-2030)

14.4.11.6. Market Revenue and Forecast, by End-use (2017-2030)

14.4.11.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.2. Market Revenue and Forecast, by Technology (2017-2030)

14.5.3. Market Revenue and Forecast, by Type (2017-2030)

14.5.4. Market Revenue and Forecast, by Application (2017-2030)

14.5.5. Market Revenue and Forecast, by Usability (2017-2030)

14.5.6. Market Revenue and Forecast, by End-use (2017-2030)

14.5.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.8.2. Market Revenue and Forecast, by Technology (2017-2030)

14.5.8.3. Market Revenue and Forecast, by Type (2017-2030)

14.5.8.4. Market Revenue and Forecast, by Application (2017-2030)

14.5.8.5. Market Revenue and Forecast, by Usability (2017-2030)

14.5.8.6. Market Revenue and Forecast, by End-use (2017-2030)

14.5.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Technology (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Type (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Application (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Usability (2017-2030)

14.5.9.6. Market Revenue and Forecast, by End-use (2017-2030)

14.5.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)

Chapter 15. Company Profiles

15.1. Crossject

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Portal Instruments

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. NuGen Medical Devices

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Inovio Pharmaceuticals

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Antares Pharma, Inc

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Aijex Pharma International Inc.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Ferring B.V.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Penjet Corporation

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Medical International Technology Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers